SIC 5912 – Drug Stores and Proprietary Stores
Valuation | |
---|---|
Market Cap ($M) | 72,648.30 |
Enterprise Value ($M) | 129,415.30 |
Book Value ($M) | 75,111.00 |
Book Value / Share | 59.71 |
Price / Book | 0.97 |
NCAV ($M) | -107,418.00 |
NCAV / Share | -85.39 |
Price / NCAV | -0.68 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | 0.04 |
Return on Assets (ROA) | 0.03 |
Return on Equity (ROE) | 0.10 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 0.66 |
Current Ratio | 0.86 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 69,952.00 |
Assets | 252,481.00 |
Liabilities | 177,370.00 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 356,623.00 |
Operating Income | 13,933.00 |
Net Income | 8,344.00 |
Earnings Per Share Diluted | n/a |
Earnings Per Share Basic | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | 13,426.00 |
Cash from Investing | -20,889.00 |
Cash from Financing | 2,683.00 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G/A | Vanguard Group Inc | 9.14 | 0.13 | |
13G/A | BlackRock Inc. | 6.80 | -9.98 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
1,537,495 | 7,061,555 | 21.77 | |
721,582 | 4,771,450 | 15.12 | |
1,002,402 | 5,788,269 | 17.32 | |
1,682,419 | 12,608,609 | 13.34 | |
(click for more detail) |